In a clinical controlled trial, Xue (48) found that the BDNF level of perimenopausal depression patients who took venlafaxine capsule increased, the HAMD score and depression symptoms improved significantly, and the good or bad drug effect was related to the BDNF level. Here, BDNF is linked to depressive symptom measurement.